Kirill Osipov comments on regulation of dependent inventions in Russia

Mr. Kirill Osipov, the Head of Legal Department, commented on regulation of dependent inventions in Russia for the newspaper “Pharmvestnik” in the light of the Moscow Arbitration Court’s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide.

More details are available at Pharmvestnik’s website.

Pharmvestnik is the leading specialized weekly newspaper covering the Russian pharmaceutical and related industries with a circulation of 16 200 copies. The newspaper has been issued since 1994.

Make an enquiry

Latest News

Kirill Osipov comments on regulation of dependent inventions in Russia

2018-06-14

Mr. Kirill Osipov, the Head of Legal Department, commented on regulation of dependent inventions in Russia for the newspaper “Pharmvestnik” in the...

Read more
ARS-Patent has been included into IAM Patent 1000

2018-06-14

World's leading IP business media platform, IAM magazine, has published the list of the World’s Leading Patent Professionals 2018. ARS-Patent has b...

Read more

View all our News

MEET WITH US

Pavel Vorobev is visiting BIO International Convention 2018 in Boston

2018-06-06

Pavel Vorobev, the patent attorney, is attending the BIO International Convention in Boston on June 1-7, 2018. The BIO International Convention is th...

Read more
Mr. Vladimir Rybakov will participate in the FICPI World Congress 2018 in Toronto

2018-05-23

Mr. Vladimir Rybakov, senior partner of “ARS-Patent”, will take part in the FICPI World Congress on June 3-10, 2018. The working program will fe...

Read more

See all Events

Back top